30 closest matches · ranked by relevance
Eyebrow Hypotrichosis
Primary: Percentage of Participants With at Least a 1-Grade Increase (Improvement) in the 4-Point Global Eyebrow Assessment (GEBA) Scale — 83.9; 77.1; 43.0 percentage of…
Eyelash Hypotrichosis
Primary: Percentage of Subjects Satisfied With Latisse® — 92.48 Percentage of Subjects
Alopecia Areata · Alopecia Totalis · Alopecia Universalis
Primary: Clinician's Eyebrow Assessment — 0 score on a scale
Idiopathic Eyelash Hypotrichosis
Primary: Percentage of Participants With at Least a 1-Grade Increase (Improvement) From Baseline in the Investigator's Assessment of Overall Eyelash Prominence (GEA) — 82.4…
Eyelash Hypotrichosis · Alopecia Areata
Primary: Percentage of Participants With Adverse Events — 35.4; 43.5 Percentage of participants
Hypotrichosis
Primary: Percentage of Treatment Responders in Overall Eyelash Prominence at Month 4 — 69.6; 48.8 Percentage of Patients
Hypotrichosis
Primary: Percentage of Treatment Responders at Month 4 — 39.3; 10.9 Percentage of Subjects
Brow Ptosis
Primary: Eyebrow Position — -3.22 mm
Eyelash Hypotrichosis
Primary: Percentage of Participants With at Least a 1-Grade Increase in Overall Eyelash Prominence Using the Global Eyelash Assessment Scale (GEA) — 77.3; 17.6 Percentage of…
Male Pattern Hair Loss · Androgenetic Alopecia
Primary: Percent Change in Target Area Total Hair Count — -2.6; 27.4; 4.9; -5.8 percentage change in total hair count
Eyelash Hypotrichosis
Primary: Percentage of Participants With at Least a 1-Grade Increase in Overall Eyelash Prominence Using the Global Eyelash Assessment Scale (GEA) — 88.9; 27.8 Percentage of…
Health
Primary: Eyelash Length as Measured by Digital Image Analysis (DIA) — 7.33 Millimeters (mm)
Dermatochalasis
Primary: Graded Change in Dermatochalasis — .2679 units on a scale
Alopecia Areata
Primary: Change From Baseline in the Severity of Alopecia Tool (SALT) Score at Week 24 — -6.3; 2.3 score on a scale
Eyelash Hypotrichosis
Primary: Change From Baseline in Eyelash Length at Month 3 — 5.65; 5.68; 5.95; 0.74 millimeters (mm)
Eyelashes
Primary: Percentage of Participants Experiencing at Least a 1-grade Increase on the Global Eyelash Assessment (GEA) Scale From Baseline to Week 16 — 5.1; 2.1; 14.6; 7.8…
Healthy Volunteers
Primary: Inter-rater Reliability of Physician Raters Using the Global Eyebrow Assessment (GEBA) Scale — 0.889 Kendall's W
Hypertrichosis
Primary: Efficacy of Bimatoprost in Lengthening of Eyelashes — 2; 1.1 mm
Alopecia · Baldness
Primary: Change From Baseline in Target Area Hair Count (TAHC) — 153.1; 161.1; 145.2; 163.0 terminal hairs/cm^2
Alopecia · Alopecia, Androgenetic · Baldness
Primary: Maximum Plasma Level (Cmax) Following a Single Dose of Bimatoprost — 0.552; 1.77; 5.58 Picograms/Milliliter (pg/mL)
Trichotillomania
Primary: Mass General Hair Pulling Scale — -7.8 units on a scale
Androgenetic Alopecia
Primary: Incidence of Treatment-emergent Adverse Events (Safety) — 0 adverse events
Alopecia · Alopecia, Androgenetic · Baldness
Primary: Change From Baseline in Target Area Hair Count (TAHC) — 135.0; 145.7; 151.5; 143.7 terminal hairs/cm^2
Lower Eyelid Steatoblepharon (Excess Eyelid Fat)
Primary: Lower Eyelid Steatoblepharon Severity (LESS) Score--Clinician-Reported — 27; 6 participants — p=0.020
Focal Dystonia
Primary: Time Until Jankovic Blepharospasm Rating Scale (JBRS) Reverts Back to Baseline — 3.71; 3.03 month
Glabellar Frown Lines (GL)
Primary: Investigator's Assessment of GL Severity at Maximum Frown Using the Facial Wrinkle Scale (FWS). — 1; 0; 0; 2 Participants
Hypotrichosis
Primary: Percentage of Participants Who Are Satisfied or Very Satisfied With Their Eyelashes Overall — 67.4; 7.1 Percentage of participants
Androgenic Alopecia
Primary: Scalp Hair Density — 1.46; 2.58; -4.10; 6.68 Change from baseline (No. of hairs/cm2)
Acquired Blepharoptosis
Primary: Percentage of Subjects With Treatment-Emergent Adverse Events [Safety and Tolerability]) — 0; 0; 0 Participants
Alopecia Areata
Primary: Likelihood of Depressive Episodes — 1217; 3576 Participants